Logo image
Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey
Journal article   Open access   Peer reviewed

Gender differences in medication use and cigarette smoking cessation: results from the International Tobacco Control Four Country Survey

Philip H Smith, Karin A Kasza, Andrew Hyland, Geoffrey T Fong, Ron Borland, Kathleen Brady, Matthew J Carpenter, Karen Hartwell, K Michael Cummings and Sherry A McKee
Nicotine & tobacco research, v 17(4), pp 463-472
01 Apr 2015
PMID: 25762757
url
https://europepmc.org/articles/pmc4402353View
Published, Version of Record (VoR)Open Access (License Unspecified) Open
url
https://doi.org/10.1093/ntr/ntu212View
Published, Version of Record (VoR) Open

Abstract

Adolescent Adult Australia - epidemiology Benzazepines - therapeutic use Canada - epidemiology Female Gender Identity Humans Longitudinal Studies Male Middle Aged Motivation Nicotine - therapeutic use Nicotinic Agonists - therapeutic use Quinoxalines - therapeutic use Smoking - epidemiology Smoking Cessation - methods Smoking Prevention Substance Withdrawal Syndrome - drug therapy United Kingdom - epidemiology United States - epidemiology Varenicline
There is conflicting evidence for gender differences in smoking cessation, and there has been little research on gender differences in smoking cessation medication (SCM) use and effectiveness. Using longitudinal data from the International Tobacco Control Four Country Surveys (ITC-4) conducted in the United Kingdom, the United States, Canada, and Australia, we examined gender differences in the incidence of quit attempts, reasons for quitting, use of SCMs, reasons for discontinuing use of SCMs, and rates of smoking cessation. Data were analyzed from adult smokers participating in the ITC-4, annual waves 2006-2011 (n = 7,825), as well as a subsample of smokers (n = 1,079) who made quit attempts within 2 months of survey. Adjusted modeling utilized generalized estimating equations. There were no gender differences in the likelihood of desire to quit, plans to quit, or quit attempts between survey waves. Among quit attempters, women had 31% lower odds of successfully quitting (OR = 0.69; 95% CI = 0.51, 0.94). Stratified by medication use, quit success was lower among women who did not use any SCMs (OR = 0.59; 95% CI = 0.39, 0.90), and it was no different from men when medications were used (OR = 0.73; 95% CI = 0.46, 1.16). In particular, self-selected use of nicotine patch and varenicline contributed to successful quitting among women. Women may have more difficulty quitting than men, and SCMs use may help attenuate this difference.

Metrics

5 Record Views
160 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Public, Environmental & Occupational Health
Substance Abuse
Logo image